External reports (aggregated public sources), Value Investors Club

Value Investors Club

External reports (aggregated public sources)

Equity Bottom-Up

<ul><li>Knight Therapeutics is a specialty pharmaceutical company based in Montreal with operations in Canada and Latin America</li><li>Founded in 2014 by Jonathan Goodman and currently led by Samira Sakhia</li><li>Focuses on acquiring, in-licensing, marketing, and distributing pharmaceutical specialty products without conducting clinical research activities, with an EV of $430M and a market cap of $530M</li></ul><p><em>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.</em></p>

Knight Therapeutics is a specialty pharmaceutical company based in Montreal with operations in Canada and Latin AmericaFounded in 2014 by Jonathan Goodman and currently led by Samira SakhiaFocuses on acquiring, in-licensing, marketing, and distributing pharmaceutical specialty products without conducting clinical research activities, with an EV of $430M and a market cap of $530MThis content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Knight Therapeutics Inc (GUD.) - Thursday, Mar 28, 2024

Canada

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company acquires and licenses pharmaceutical products. Knight offers its products to the healthcare industry around the world.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Knight Therapeutics (GUD CN)

Knight Therapeutics Inc (GUD.) - Thursday, Mar 28, 2024

Knight Therapeutics is a specialty pharmaceutical company based in Montreal with operations in Canada and Latin America. Founded in 2014 by...

Value Investors Club

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)